Please use this identifier to cite or link to this item:
Title: Natural and synthetic retinoids in preclinical colorectal cancer models
Authors: Abdel-Samad, Rana 
Aouad, Patrick
Darwiche, Nadine
Affiliations: Faculty of Health Sciences 
Keywords: Colorectal cancer
Natural retinoids
Preclinical models
Retinoic acid
Synthetic retinoids
Issue Date: 2019
Publisher: National Library of Medicine
Part of: Anti-Cancer Drugs
Volume: 30
Issue: 7
Start page: 655
End page: 669
Colorectal cancer (CRC) remains a leading cause of cancer-related morbidity and mortality worldwide. Although targeted therapy in combination with chemotherapy in CRC prolongs the overall survival of patients with metastatic disease, acquired resistance and relapse hinder their clinical benefits. Moreover, patients with some specific genetic profile are unlikely to benefit from targeted therapy, suggesting the need for safe and effective treatment strategies. Retinoids, comprising of natural and synthetic analogs, are a class of chemical compounds that regulate cellular proliferation, differentiation, and cell death. Retinoids have been used in the clinic for several leukemias and solid tumors, either as single agents or in combination therapy. Furthermore, retinoids have shown potent chemotherapeutic and chemopreventive properties in different cancer models, including CRC. In this review, we summarize the major preclinical findings in CRC in which natural and synthetic retinoids showed promising antitumor activities and stress on the proposed mechanisms of action. Understanding of the retinoids' antitumor mechanisms would provide insights to support and warrant their development in the management of CRC.
ISSN: 09594973
DOI: 10.1097/CAD.0000000000000802
Open URL: Link to full text
Type: Journal Article
Appears in Collections:Department of Medical Laboratory Sciences

Show full item record


checked on Jun 8, 2024

Record view(s)

checked on Jun 13, 2024

Google ScholarTM


Dimensions Altmetric

Dimensions Altmetric

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.